No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Acute myeloid leukemia 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2 | Adipocytokine signaling pathway 2 genes, 2 drugs (DrugBank) and 52 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
3 | Adrenergic signaling in cardiomyocytes 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
4 | African trypanosomiasis 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
5 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 2 drugs (DrugBank) and 35 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
6 | Aldosterone synthesis and secretion 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
7 | Allograft rejection 2 genes, 3 drugs (DrugBank) and 24 diseases shown |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
8 | Alzheimer disease 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
9 | Amoebiasis 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
10 | AMPK signaling pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
11 | Amyotrophic lateral sclerosis (ALS) 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
12 | Antifolate resistance 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
13 | Antigen processing and presentation 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
14 | Apelin signaling pathway 2 genes, 2 drugs (DrugBank) and 45 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
15 | Apoptosis 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
16 | Asthma 3 genes, 4 drugs (DrugBank) and 27 diseases shown |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
17 | Autoimmune thyroid disease 1 gene, 2 drugs (DrugBank) and 4 diseases shown |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
18 | Autophagy - animal 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
19 | Autophagy - other 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
20 | Breast cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
21 | C-type lectin receptor signaling pathway 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
22 | Calcium signaling pathway 6 genes, 3 drugs (DrugBank) and 19 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
4件: CHRM1, CHRM2, CHRM3, CHRM5 |
D01000 |
Bethanechol |
1件: 98 |
1件: CYSLTR1 |
D00529 |
Montelukast |
5件: 13, 46, 85, 98, 228 |
D08229 |
23 | cAMP signaling pathway 2 genes, 1 drug (DrugBank) and 1 disease shown |
2件: CHRM1, CHRM2 |
D01000 |
Bethanechol |
1件: 98 |
24 | Cellular senescence 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
25 | Central carbon metabolism in cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
26 | cGMP-PKG signaling pathway 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
27 | Chagas disease (American trypanosomiasis) 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
28 | Choline metabolism in cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
29 | Cholinergic synapse 5 genes, 1 drug (DrugBank) and 1 disease shown |
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D01000 |
Bethanechol |
1件: 98 |
30 | Collecting duct acid secretion 2 genes, 4 drugs (DrugBank) and 20 diseases shown |
2件: ATP4A, ATP4B |
D08903 |
Dexlansoprazole |
1件: 98 |
D01984 |
Esomeprazole |
6件: 6, 46, 86, 98, 298, 299 |
D04056 |
D07917 |
D09339 |
D00355 |
Lansoprazole |
6件: 63, 71, 98, 166, 222, 299 |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
31 | Colorectal cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
32 | Cortisol synthesis and secretion 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
33 | Cushing syndrome 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
34 | Cytokine-cytokine receptor interaction 3 genes, 4 drugs (DrugBank) and 24 diseases shown |
1件: IL4R |
D10354 |
Dupilumab |
1件: 98 |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
35 | Dilated cardiomyopathy (DCM) 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
36 | EGFR tyrosine kinase inhibitor resistance 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
37 | Endocrine resistance 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
38 | Epstein-Barr virus infection 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
39 | ErbB signaling pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
40 | Fc epsilon RI signaling pathway 3 genes, 4 drugs (DrugBank) and 27 diseases shown |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
41 | Fluid shear stress and atherosclerosis 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
42 | GABAergic synapse 16 genes, 1 drug (DrugBank) and 8 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
43 | Gastric acid secretion 3 genes, 5 drugs (DrugBank) and 20 diseases shown |
2件: ATP4A, ATP4B |
D08903 |
Dexlansoprazole |
1件: 98 |
D01984 |
Esomeprazole |
6件: 6, 46, 86, 98, 298, 299 |
D04056 |
D07917 |
D09339 |
D00355 |
Lansoprazole |
6件: 63, 71, 98, 166, 222, 299 |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
1件: CHRM3 |
D01000 |
Bethanechol |
1件: 98 |
44 | Gastric cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
45 | Glioma 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
46 | Graft-versus-host disease 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
47 | Growth hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
48 | Hematopoietic cell lineage 3 genes, 4 drugs (DrugBank) and 24 diseases shown |
1件: IL4R |
D10354 |
Dupilumab |
1件: 98 |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
49 | Hepatitis B 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
50 | Hepatitis C 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
51 | Hepatocellular carcinoma 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
52 | Herpes simplex virus 1 infection 2 genes, 2 drugs (DrugBank) and 52 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
53 | HIF-1 signaling pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
54 | Human cytomegalovirus infection 2 genes, 2 drugs (DrugBank) and 52 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
55 | Human immunodeficiency virus 1 infection 2 genes, 2 drugs (DrugBank) and 52 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
56 | Human papillomavirus infection 2 genes, 2 drugs (DrugBank) and 52 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
57 | Human T-cell leukemia virus 1 infection 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
58 | Hypertrophic cardiomyopathy (HCM) 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
59 | IL-17 signaling pathway 2 genes, 3 drugs (DrugBank) and 24 diseases shown |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
60 | Inflammatory bowel disease (IBD) 3 genes, 4 drugs (DrugBank) and 24 diseases shown |
1件: IL4R |
D10354 |
Dupilumab |
1件: 98 |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
61 | Influenza A 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
62 | Insulin resistance 2 genes, 2 drugs (DrugBank) and 52 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
63 | Insulin secretion 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CHRM3 |
D01000 |
Bethanechol |
1件: 98 |
64 | Insulin signaling pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
65 | Intestinal immune network for IgA production 1 gene, 2 drugs (DrugBank) and 4 diseases shown |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
66 | JAK-STAT signaling pathway 3 genes, 4 drugs (DrugBank) and 39 diseases shown |
1件: IL4R |
D10354 |
Dupilumab |
1件: 98 |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
67 | Kaposi sarcoma-associated herpesvirus infection 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
68 | Legionellosis 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
69 | Leishmaniasis 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
70 | Longevity regulating pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
71 | Longevity regulating pathway - multiple species 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
72 | Malaria 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
73 | MAPK signaling pathway 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
74 | Metabolic pathways 2 genes, 4 drugs (DrugBank) and 20 diseases shown |
2件: ATP4A, ATP4B |
D08903 |
Dexlansoprazole |
1件: 98 |
D01984 |
Esomeprazole |
6件: 6, 46, 86, 98, 298, 299 |
D04056 |
D07917 |
D09339 |
D00355 |
Lansoprazole |
6件: 63, 71, 98, 166, 222, 299 |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
75 | MicroRNAs in cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
76 | Morphine addiction 16 genes, 1 drug (DrugBank) and 8 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
77 | mTOR signaling pathway 2 genes, 2 drugs (DrugBank) and 52 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
78 | Natural killer cell mediated cytotoxicity 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
79 | Necroptosis 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
80 | Neuroactive ligand-receptor interaction 24 genes, 9 drugs (DrugBank) and 29 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D01000 |
Bethanechol |
1件: 98 |
1件: CYSLTR1 |
D00529 |
Montelukast |
5件: 13, 46, 85, 98, 228 |
D08229 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
1件: NR3C1 |
D00689 |
Beclomethasone dipropionate |
2件: 97, 98 |
D07495 |
D00246 |
Budesonide |
10件: 66, 85, 93, 94, 95, 96, 97, 98, 228, 299 |
D07981 |
Fluticasone |
4件: 98, 228, 299, 306 |
D01708 |
Fluticasone propionate |
4件: 98, 228, 299, 306 |
D00690 |
Mometasone furoate |
1件: 98 |
81 | NF-kappa B signaling pathway 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
82 | Nicotine addiction 16 genes, 1 drug (DrugBank) and 8 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
83 | NOD-like receptor signaling pathway 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
84 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
85 | Osteoclast differentiation 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
86 | Oxidative phosphorylation 2 genes, 4 drugs (DrugBank) and 20 diseases shown |
2件: ATP4A, ATP4B |
D08903 |
Dexlansoprazole |
1件: 98 |
D01984 |
Esomeprazole |
6件: 6, 46, 86, 98, 298, 299 |
D04056 |
D07917 |
D09339 |
D00355 |
Lansoprazole |
6件: 63, 71, 98, 166, 222, 299 |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
87 | Pancreatic cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
88 | Pancreatic secretion 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CHRM3 |
D01000 |
Bethanechol |
1件: 98 |
89 | Pathogenic Escherichia coli infection 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
90 | Pathways in cancer 4 genes, 5 drugs (DrugBank) and 48 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: IL4R |
D10354 |
Dupilumab |
1件: 98 |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
91 | PD-L1 expression and PD-1 checkpoint pathway in cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
92 | Pertussis 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
93 | Phospholipase D signaling pathway 3 genes, 3 drugs (DrugBank) and 48 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
94 | PI3K-Akt signaling pathway 4 genes, 3 drugs (DrugBank) and 36 diseases shown |
2件: CHRM1, CHRM2 |
D01000 |
Bethanechol |
1件: 98 |
1件: IL4R |
D10354 |
Dupilumab |
1件: 98 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
95 | Prostate cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
96 | Proteoglycans in cancer 2 genes, 2 drugs (DrugBank) and 52 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
97 | Regulation of actin cytoskeleton 5 genes, 1 drug (DrugBank) and 1 disease shown |
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D01000 |
Bethanechol |
1件: 98 |
98 | Renin secretion 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
99 | Renin-angiotensin system 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
100 | Retrograde endocannabinoid signaling 16 genes, 1 drug (DrugBank) and 8 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
101 | Rheumatoid arthritis 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
102 | RIG-I-like receptor signaling pathway 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
103 | Salivary secretion 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CHRM3 |
D01000 |
Bethanechol |
1件: 98 |
104 | Serotonergic synapse 3 genes, 1 drug (DrugBank) and 8 diseases shown |
3件: GABRB1, GABRB2, GABRB3 |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
105 | Shigellosis 2 genes, 2 drugs (DrugBank) and 52 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
106 | Sphingolipid signaling pathway 2 genes, 2 drugs (DrugBank) and 26 diseases shown |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
107 | Systemic lupus erythematosus 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
108 | T cell receptor signaling pathway 2 genes, 3 drugs (DrugBank) and 24 diseases shown |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
109 | Taste transduction 7 genes, 2 drugs (DrugBank) and 8 diseases shown |
1件: CHRM3 |
D01000 |
Bethanechol |
1件: 98 |
6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
110 | TGF-beta signaling pathway 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
111 | Th1 and Th2 cell differentiation 2 genes, 3 drugs (DrugBank) and 4 diseases shown |
1件: IL4R |
D10354 |
Dupilumab |
1件: 98 |
1件: IL5 |
D04923 |
Mepolizumab |
4件: 44, 45, 98, 162 |
D08985 |
Reslizumab |
3件: 44, 45, 98 |
112 | Th17 cell differentiation 2 genes, 2 drugs (DrugBank) and 36 diseases shown |
1件: IL4R |
D10354 |
Dupilumab |
1件: 98 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
113 | Thermogenesis 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
114 | Thyroid hormone signaling pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
115 | TNF signaling pathway 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
116 | Toll-like receptor signaling pathway 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
117 | Toxoplasmosis 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
118 | Tuberculosis 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
119 | Type I diabetes mellitus 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
120 | Type II diabetes mellitus 2 genes, 2 drugs (DrugBank) and 52 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
121 | Vascular smooth muscle contraction 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
122 | Viral protein interaction with cytokine and cytokine receptor 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
123 | Yersinia infection 1 gene, 1 drug (DrugBank) and 23 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |